Evidence map›Paper›PMID 42680825›Full record

ArticleNature biotechnology2026

A pervasive RT-qPCR artifact inflates RNA knockdown by RNA-targeting CRISPR.

Leslie Watkins, Alan Zhu, Bin Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Architecture of a DNA-guided Cas12a.Nature structural & molecular biology · 2026
    Article
  2. From reading to writing.Nature biotechnology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Leslie WatkinsDepartment of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-7163-2588
Alan ZhuDepartment of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Bin WuDepartment of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USA. bwu20@jhmi.edu.ORCID http://orcid.org/0000-0002-9442-3041

Funding

BIOCHEMISTRY, CELLULAR AND MOLECULAR BIOLOGY PROGRAMT32GM007445 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GREEN, RACHEL · 1985 to 2021
$24.1M
Developing optogenetic and chemogenetic approaches to control RNA metabolism in live cellsR01GM136897 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI WU, BIN · 2021 to 2024
$1.8M
Probe translation regulation by imaging single protein-mRNA interaction in live cellsR35GM161776 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Bin Wu · 2026 to 2026
$426k
U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01GM136897U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM161776U.S. Department of Health & Human Services | National Institutes of Health (NIH) T32GM007445
6 · The paper itself

Abstract

Knockdown efficiency of RNA-targeting CRISPR systems is commonly measured by quantitative polymerase chain reaction with reverse transcription (RT-qPCR). Here we discovered that guide RNAs copurify during RNA extraction and inhibit RT-qPCR for amplicons spanning or upstream of the guide RNA binding site, resulting in overestimation of knockdown efficiency across all CRISPR systems tested. We recommend using a processive reverse transcriptase with strong strand-displacing activity, with orthogonal methods, to ensure accurate quantification when using RT-qPCR.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.